Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50